World Leukemia Day 2025

04. September 2025

Standing Together in the Fight Against Leukemia

World Leukemia Day is a global opportunity to raise awareness about this challenging blood cancer and to highlight the critical importance of early diagnosis and effective treatment. At Nihon Kohden, we are committed to supporting healthcare professionals by delivering reliable in-vitro diagnostic (IVD) solutions that empower clinicians to detect and monitor hematological conditions with confidence.

Smarter Hematology Tools for Early Detection

Leukemia often presents with subtle changes in blood parameters that require precise and sensitive detection. Nihon Kohden’s hematology analyzers—Celltac G MEK-9100 and Celltac G+ MEK-9200—are designed to provide:

  • Fast and accurate results for Complete Blood Count (CBC) and 5-part differential
  • Advanced detection capabilities, flagging abnormal white blood cell distributions or blast cells
  • Reticulocyte parameters for deeper insights into bone marrow function and disease monitoring

By combining advanced flow cytometry, laser scatter technology, and efficient sample handling, these analyzers help laboratories identify abnormalities earlier, enabling timely follow-up and improved patient outcomes.

Streamlined Workflows for Critical Diagnostics

Efficiency in laboratory operations directly impacts patient care. With throughput of up to 90 samples per hour, continuous loading racks, and smart sample tracking, our systems are built to optimize laboratory workflows. The Smart ColoRack Match System further enhances efficiency by helping to quickly locate abnormal or critical samples, ensuring faster reporting and clinical action.

Our Commitment

On World Leukemia Day, Nihon Kohden stands in solidarity with patients, families, and healthcare professionals worldwide. Every accurate test result brings us one step closer to better care and outcomes. By continuing to innovate in hematology, we aim to empower laboratories with smarter tools that truly make a difference in the fight against leukemia.